Available Brands
Did you find this information helpful?
Author Details
Written By
Sakshi Anil More
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 18 May 2026 | 08:49 AM (IST)
Want to know more?
Read Our Editorial Policy
Quick Summary
DOLUTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
Last updated on 18 May 2026 | 08:49 AM (IST)
DOLUTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
Background and Date of approval DOLUTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
Dolutegravir, Emtricitabine and Tenofovir Alafenamide is a combination regimen consisting of antiviral medications, which was approved for its medical use on December 2020.
Uses of DOLUTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
Dolutegravir, Emtricitabine and Tenofovir Alafenamide has been developed to treat Human Immunodeficiency Virus (HIV-1). Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablet is indicated as a complete regimen for treating adults and children weighing above 25kg infected with HIV 1.
How is DOLUTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE administered?
Dolutegravir, Emtricitabine and Tenofovir Alafenamide is available as film coated tablets consisting of 50mg of Dolutegravir, 200mg of Emtricitabine and 25mg of Tenofovir Alafenamide. The usual recommended dosage of this combination regimen is one tablet everyday with or without food.
Side Effects of DOLUTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
The common side effects that are likely to occur while you are on the treatment with Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablet are insomnia, tiredness, headache, diarrhoea, rash, pain, depression, anxiety, urticaria. Some serious adverse reactions include bone loss, worsening of Hepatitis B, kidney injury, immune reconstitution syndrome, lactic acidosis, liver toxicity and enlargement. If you experience any allergic reactions after taking this tablet, report to your doctor immediately.
Warnings
Do not take this medication if you have experienced hypersensitivity reactions to Dolutegravir, Emtricitabine or Tenofovir Alafenamide. Patients who are diagnosed with pancreatitis or at risk of pancreatitis should take this combination medicine with caution. During the Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablet treatment, your doctor may periodically monitor your blood counts, bone mineral density, liver and kidney parameters to prevent serious complications. Report to your doctor if you have had a history of heart failure, pancreatitis, bone disease, fractures, liver or kidney problems.
Precautions
Adults of childbearing potential should consider using an effective contraceptive to prevent unwanted pregnancy. If you are pregnant or think you might be pregnant, your physician might suggest an alternative treatment as this combination regimen is not recommended during early pregnancy. Breastfeeding is not recommended due to potential transmission of HIV from mother to the baby.
Word of Advice
Dolutegravir, Emtricitabine and Tenofovir Alafenamide can make you feel tired. Hence, you should avoid driving or handling machines during this treatment.
Frequently Asked Questions
Q1.
What should you not take with Dolutegravir, Emtricitabine and tenofovir Alafenamide?
It is not recommended to take dolutegravir, Emtricitabine and tenofovir Alafenamide tablet with dofetilide. Tell your healthcare provider if you are taking any other medications, over-the counter drugs, vitamin or herbal supplements.
Q2.
Is it safe to use Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablet during pregnancy and breastfeeding?
If you are pregnant or think you might be pregnant, your physician might suggest an alternative treatment as this combination regimen is not recommended during early pregnancy. Breastfeeding is not recommended due to potential transmission of HIV from mother to the baby.
Q3.
3. When should you report to your healthcare provider?
Reach out to your healthcare provider if you experience symptoms of hypersensitivity reactions or lactic acidosis.
Q4.
What are the required laboratory parameters prior to starting this treatment?
If you are an adolescent or adult of childbearing potential, your healthcare provider will perform pregnancy test before prescribing this treatment. other prominent tests include test for HBV infection, serum creatinine, estimated creatinine clearance, urine glucose and urine protein.
Q5.
How do you know if you are hypersensitive to Dolutegravir, Emtricitabine or Tenofovir Alafenamide?
Watch out for symptoms like severe rash, rash accompanied by fever, muscle pain, extreme tiredness, facial edema, breathing difficulty, blisters and peeling of skin and reach out to your healthcare provider immediately if you experience any of the above symptoms.
Q6.
What are some of the long-term side effects of this combination regimen?
Some serious side effects of this combination regimen include worsening of hepatitis B, bone loss, kidney injury, pancreatitis, immune reconstitution syndrome, liver toxicity and hypersensitivity reactions.
Q7.
What are the symptoms of lactic acidosis?
Unusual weakness, tiredness, muscle pain, trouble breathing, stomach pain, nausea, vomiting, dizziness, lightheadedness, irregular heartbeat and feeling cold especially in your arms and legs are the most prominent symptoms of lactic acidosis.
References
- KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
- Laurus Generics Inc., U.S. Food and Drug Administration, [Revised on Dec 2020] [Accessed on 27th Aug 2022], https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/213681PI.pdf
- Guangdi L, et al., Approved HIV reverse transcriptase inhibitors in the past decade, Acta Pharmaceutica Sinica B, Published on Apr 2022, 12(4), 1567-1590, [Accessed on 27th Aug 2022], https://www.sciencedirect.com/science/article/pii/S2211383521004433
Disclaimer
The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details consult your doctor about your medical condition to know if you are eligible to receive this treatment.
